Lument Finance Trust, Inc. — Q1 2022 Form 10-Q
Business context and period. Lument Finance Trust is an externally managed mortgage REIT focused primarily on transitional commercial real estate debt, especially floating-rate multifamily loans. This unaudited filing covers the three months ended March 31, 2022, with balance-sheet comparisons to December 31, 2021.
Financial and operating highlights
- Portfolio: Commercial mortgage loans totaled $1.078 billion across 71 senior secured loans, up from $1.002 billion and 66 loans at year-end. All loans were current; the company reported no nonaccrual, impaired, or maturity-default loans and no loan-loss allowance. The portfolio was 94.2% multifamily by collateral type.
- Revenue and earnings: Loan interest income was $10.0 million versus $7.5 million a year earlier. Net interest income rose to $5.09 million from $4.52 million. Consolidated net income increased to $2.95 million from $2.81 million, but net income attributable to common stockholders fell to $1.77 million from $2.80 million. Basic and diluted EPS was $0.05 versus $0.11.
- Expenses and margins: Total expenses increased to $2.30 million from $1.80 million. The filing does not provide a clearly identified net interest margin percentage.
- Cash flow: Operating activities provided $4.56 million, investing activities used $53.24 million, and financing activities provided $77.59 million. Cash, cash equivalents and restricted cash increased $28.91 million. Unrestricted cash was $45.85 million at quarter-end, compared with $14.75 million at year-end.
- Debt and leverage: CLO liabilities were $827.4 million carrying value ($833.8 million principal); the $47.75 million secured term loan bears a fixed 7.25% rate and matures in February 2026. The company reported total debt-to-equity of 3.5x on a GAAP basis and recourse debt-to-equity of 0.2x. CLO debt is non-recourse to the company and is not subject to margin calls. The company reported compliance with its term-loan covenants.
- Capital and distributions: A February rights offering issued 27.28 million common shares at $3.06 each, generating about $83.5 million gross and $81.1 million net proceeds. Common equity book value per share was $3.62, down from $4.38 at year-end, primarily reflecting the substantial increase in shares issued. The company declared a $0.06 common dividend per share and a $0.49219 Series A preferred dividend per share.
Material changes versus the prior comparable period
- Net interest income increased by approximately $0.57 million, principally as the loan portfolio expanded; higher CLO balances and other funding and portfolio factors partly offset the increase.
- Common-stockholder income declined by approximately $1.04 million, despite higher consolidated net income. Increased expenses and $1.18 million of preferred dividends (versus $3,708 in Q1 2021) more than offset higher net interest and other income. The common share count also increased materially following the rights offering.
- Operating cash flow improved to $4.56 million from $3.17 million, while investing cash flow shifted to a $53.24 million outflow from a $28.64 million inflow, reflecting loan purchases exceeding principal repayments.
- The portfolio’s weighted average internal risk rating was 2.1 versus 2.3 at year-end; on the company’s scale, lower ratings indicate lower risk. The filing attributes the improvement mainly to new loan purchases and portfolio rating movements.
Outlook, risks, contingencies, and notable items
- Management stated that existing equity proceeds, operating cash flow, and available borrowing capacity should meet anticipated short-term liquidity needs. Long-term funding needs may require additional debt or equity financing. No specific earnings or return guidance was provided.
- Management expects to deploy recently raised capital into target investments, but notes deployment may take time and temporarily reduce net interest income. The larger equity base may also increase management fees and affect the incentive-fee hurdle and expense reimbursement cap.
- Most investments and all CLO obligations were LIBOR-linked at quarter-end: 93.9% of commercial mortgage loans by principal balance and 100% of CLO obligations referenced one-month U.S. LIBOR. The company is transitioning new originations to SOFR and warns that LIBOR replacement terms may affect results.
- Rising rates may increase loan interest income, but could strain borrowers’ debt-service capacity and refinancing ability. Credit, real estate market, prepayment, liquidity, and COVID-19-related risks remain. Management said COVID-19 had not significantly affected Q1 results, but future effects remain uncertain.
- Unfunded commitments associated with loans held in the CLO and an affiliated trust were $81.8 million and $9.1 million, respectively; these were not recorded as balance-sheet liabilities. A legacy backstop guarantee had a stated maximum potential exposure of $348 million, but MAXEX Clearing LLC assumed the obligations and the company reported no known circumstances expected to trigger payment.
- No material litigation or COVID-19 contingencies were reported. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting.
Important facts for investors to verify
- Reconcile the common dividend disclosures: the filing reports a $0.06 per-share quarterly declaration, while a dividend table also shows $0.086 per weighted-average share. Confirm the relevant calculation and share basis.
- Assess whether portfolio performance and the favorable average risk-rating movement remain durable, particularly given the multifamily concentration and three loans rated high risk.
- Review the timing and returns on deployment of the rights-offering proceeds, and the effect of the larger equity base on fees, EPS, and book value per share.
- Monitor LIBOR-to-SOFR transition provisions, borrower sensitivity to higher rates, CLO coverage tests, and the ability to meet future funding commitments.
- Evaluate the legacy $348 million backstop exposure and the financial capacity and ongoing compliance of the party that assumed the obligations.